| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002068015A2 Modular infusion device and method |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067963A1 Compositions for lowering serum cholesterol level |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067947A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for adjuvant treatment of perianal disease |
| 09/06/2002 | WO2002067944A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for treating motion sickness |
| 09/06/2002 | WO2002067942A2 Methods of treating irritable bowel syndrome and functional dyspepsia |
| 09/06/2002 | WO2002067934A1 New use of phencynonate hydrochloride |
| 09/06/2002 | WO2002067932A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | WO2002067920A1 Remedies for chronic hepatitis c |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067906A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 09/06/2002 | WO2002067870A2 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease |
| 09/06/2002 | WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002041882A3 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002028860A3 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 09/06/2002 | WO2002016574A3 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 09/06/2002 | WO2001094612A3 Method for identifying medically valuable active substances |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001070203A3 Agent for treating hepatitis c containing ukrain |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001015553A9 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2439261A1 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434654A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123488 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |
| 09/05/2002 | US20020123468 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109858A1 Neuartige halogensubstituierte Aminodicarbonsäurederivate Novel halogen-substituted Aminodicarbonsäurederivate |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236725A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236472A1 Glycyrrhizin preparations for transmucosal absorption |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235834A1 (1r,cis)-4-(4-amino-7h-pyrr0l0[2,3- i(d)]pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/04/2002 | EP1235826A1 Quinuclidine acrylamides |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1235577A2 Protease inhibitors |
| 09/04/2002 | EP1235565A1 Use of 5ht 3 agonists for relaxing the fundus |
| 09/04/2002 | EP1235557A2 Gastroretentive controlled release pharmaceutical dosage forms |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP0969828B1 Butyrate prodrugs derived from lactic acid |
| 09/04/2002 | EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands |
| 09/04/2002 | EP0915864B1 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 09/04/2002 | EP0913151B1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0783884B1 Conagenin as preventive and remedy for diarrhea |
| 09/04/2002 | EP0764208B1 Bmp-9 compositions |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |